Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
oleh: Richard G. Langley, MD, Chiranjeev Sanyal, PhD, Aaron Situ, MSc, Sarah Alulis, MSc, Fareen Hassan, MSc, Steve Peterson, MPH, Rachel E. Teneralli, PhD, Jennifer Lee, MBA, Barkha P. Patel, PhD, Tim Disher, PhD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-06-01 |
Deskripsi
Subjek
change from baseline; guselkumab; indirect treatment comparisons; matching-adjusted indirect comparison; risankizumab; PASI